The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Nostalgic ’90s movie lovers will find it hard to forget classics like Mrs. Doubtfire, and even harder to forget Harvey ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

After watching her weight go up and down throughout her career, Whitley was recommended the injectable prescription medicine ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

Eli Lilly ( LLY 0.64%) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong ...

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.

Tonight’s Hot Topic Tuesday revisits injectable weight-loss drugs and the new discoveries coming out about the medications.